ReP USP - Resultado da busca

Artigo de periodico
Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial (2017)
Mehta, Sanjay; Sastry, Bhagavatula Kutumba Srinivasa; Souza, Rogério; Torbicki, Adam; Ghofrani, Hossein-Ardeschir; Channick, Richard N.; Delcroix, Marion; Pulido, Tomás; Simonneau, Gérald; Wlodarczyk, John; Rubin, Lewis J.; Jansa, Pavel; Hunsche, Elke; Galiè, Nazzareno; Perchenet, Loïc; Sitbon, Olivier
Fonte: CHEST. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, QUALIDADE DE VIDA, FARMACOTERAPIA, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Sanjay et al. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. CHEST, v. 151, n. 1, p. 106-118, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2016.08.1473. Acesso em: 22 out. 2025.
APA
Mehta, S., Sastry, B. K. S., Souza, R., Torbicki, A., Ghofrani, H. -A., Channick, R. N., et al. (2017). Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. CHEST, 151( 1), 106-118. doi:10.1016/j.chest.2016.08.1473
NLM
Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani H-A, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial [Internet]. CHEST. 2017 ; 151( 1): 106-118.[citado 2025 out. 22 ] Available from: https://doi.org/10.1016/j.chest.2016.08.1473
Vancouver
Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani H-A, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial [Internet]. CHEST. 2017 ; 151( 1): 106-118.[citado 2025 out. 22 ] Available from: https://doi.org/10.1016/j.chest.2016.08.1473
Artigo de periodico
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension (2017)
Galiè, Nazzareno; Jansa, Pavel; Pulido, Tomás; Channick Richard N.; Delcroix, Marion; Ghofrani, Hossein-Ardeschir; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loïc; Rubin Lewis J.; Sastry, B.K.S.; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam
Fonte: European Heart Journal. Unidade: FM
Assuntos: MORTALIDADE, CATETERISMO CARDÍACO, ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALIÈ, Nazzareno et al. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, v. 38, n. 15, p. 1147-1155, 2017Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehx025. Acesso em: 22 out. 2025.
APA
Galiè, N., Jansa, P., Pulido, T., Channick Richard N.,, Delcroix, M., Ghofrani, H. -A., et al. (2017). SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, 38( 15), 1147-1155. doi:10.1093/eurheartj/ehx025
NLM
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/eurheartj/ehx025
Vancouver
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/eurheartj/ehx025
Trabalho de evento-resumo periodico
Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy (2013)
Simonneau, Gérald; Channick, Richard; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein; Jansa, Pavel; Le Brun, Franck - Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomas; Sastry, B.; Sitbon, Olivier; Torbicki, Adam; Rubin, Lewis
Fonte: Chest. Nome do evento: CHEST 2013 Annual Meeting Abstracts. Unidade: FM
Assuntos: PROGNÓSTICO, HIPERTENSÃO PULMONAR (TERAPIA), FATORES DE RISCO, FÁRMACOS (SISTEMA RESPIRATÓRIO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMONNEAU, Gérald et al. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3. Acesso em: 22 out. 2025. , 2013
APA
Simonneau, G., Channick, R., Delcroix, M., Galiè, N., Ghofrani, H., Jansa, P., et al. (2013). Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. doi:10.1378/chest.1701395
NLM
Simonneau G, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy [Internet]. Chest. 2013 ; 144( 4): 876A.[citado 2025 out. 22 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Vancouver
Simonneau G, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy [Internet]. Chest. 2013 ; 144( 4): 876A.[citado 2025 out. 22 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Trabalho de evento-resumo periodico
Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan (2013)
Channick, Richard; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein A.; Jansa, Pavel; Le Brun, Franck - Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomas; Souza, Rogério; Sastry, B.; Sitbon, Olivier; Torbicki, Adam; Rubin, Lewis; Simonneau, Gérald
Fonte: Chest. Nome do evento: CHEST 2013 Annual Meeting Abstracts. Unidade: FM
Assuntos: ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR, FATORES DE RISCO, FÁRMACOS (SISTEMA RESPIRATÓRIO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHANNICK, Richard et al. Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3. Acesso em: 22 out. 2025. , 2013
APA
Channick, R., Delcroix, M., Galiè, N., Ghofrani, H. A., Jansa, P., Le Brun, F. -O., et al. (2013). Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. doi:10.1378/chest.1701395
NLM
Channick R, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Souza R, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 870B.[citado 2025 out. 22 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Vancouver
Channick R, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Souza R, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 870B.[citado 2025 out. 22 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Trabalho de evento-resumo periodico
Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan (2013)
Souza, Rogério; Channick, Richard; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein; Jansa, Pavel; Le Brun, Franck - Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomas; Sastry, B.; Sitbon, Olivier; Torbicki, Adam; Rubin, Lewis; Simonneau, Gérald
Fonte: Chest. Nome do evento: CHEST 2013 Annual Meeting Abstracts. Unidade: FM
Assuntos: PROGNÓSTICO, HIPERTENSÃO PULMONAR, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Rogério et al. Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3. Acesso em: 22 out. 2025. , 2013
APA
Souza, R., Channick, R., Delcroix, M., Galiè, N., Ghofrani, H., Jansa, P., et al. (2013). Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. doi:10.1378/chest.1701714
NLM
Souza R, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 879A.[citado 2025 out. 22 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Vancouver
Souza R, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 879A.[citado 2025 out. 22 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Artigo de periodico
Pulmonary arterial hypertension: bridging the present to the future (2012)
Humbert, Marc; Souza, Rogerio; Galiè, Nazzareno; McLaughlin, Vallerie; Simonneau, Gérald; Rubin, Lewis
Fonte: European respiratory review. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, ECOCARDIOGRAFIA DOPPLER, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUMBERT, Marc et al. Pulmonary arterial hypertension: bridging the present to the future. European respiratory review, v. 21, n. 126, p. 267-270, 2012Tradução . . Disponível em: https://doi.org/10.1183/09059180.00005312. Acesso em: 22 out. 2025.
APA
Humbert, M., Souza, R., Galiè, N., McLaughlin, V., Simonneau, G., & Rubin, L. (2012). Pulmonary arterial hypertension: bridging the present to the future. European respiratory review, 21( 126), 267-270. doi:10.1183/09059180.00005312
NLM
Humbert M, Souza R, Galiè N, McLaughlin V, Simonneau G, Rubin L. Pulmonary arterial hypertension: bridging the present to the future [Internet]. European respiratory review. 2012 ; 21( 126): 267-270.[citado 2025 out. 22 ] Available from: https://doi.org/10.1183/09059180.00005312
Vancouver
Humbert M, Souza R, Galiè N, McLaughlin V, Simonneau G, Rubin L. Pulmonary arterial hypertension: bridging the present to the future [Internet]. European respiratory review. 2012 ; 21( 126): 267-270.[citado 2025 out. 22 ] Available from: https://doi.org/10.1183/09059180.00005312

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos